Oryzon Genomics (MEX:ORYN) Cyclically Adjusted Book per Share: MXN22.47 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:ORYN Oryzon Genomics SA MEX:ORYN
29 GF Score
Price MXN48.59
View Full Analysis

What is Oryzon Genomics Cyclically Adjusted Book per Share?

Oryzon Genomics MEX:ORYN 29 Cyclically Adjusted Book per Share is MXN22.47 as of Jun. 2026. GuruFocus rates MEX:ORYN with a GF Score™ of 29/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Oryzon Genomics's adjusted book value per share for the three months ended in Jun. 2026 was MXN29.360. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is MXN22.47 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Oryzon Genomics's average Cyclically Adjusted Book Growth Rate was 5.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-08-09), Oryzon Genomics's current stock price is MXN48.59. Oryzon Genomics's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was MXN22.47. Oryzon Genomics's Cyclically Adjusted PB Ratio of today is 2.16.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Oryzon Genomics was 2.04. The lowest was 0.00. And the median was 0.00.


Oryzon Genomics  (MEX:ORYN) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Oryzon Genomics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=48.59/22.47
=2.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Oryzon Genomics was 2.04. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Oryzon Genomics Cyclically Adjusted Book per Share Related Terms


Oryzon Genomics Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Oryzon Genomics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oryzon Genomics Cyclically Adjusted Book per Share Chart

Oryzon Genomics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 46.51 21.56

Oryzon Genomics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.84 22.25 21.56 24.65 22.47

MEX:ORYN vs VRTX, REGN, RVMD: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Oryzon Genomics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oryzon Genomics Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oryzon Genomics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Oryzon Genomics's Cyclically Adjusted PB Ratio falls into.


MEX:ORYN
29GF Score
Oryzon Genomics SA MEX:ORYN
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oryzon Genomics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Oryzon Genomics's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=29.36/131.3300*131.3300
=29.360

Current CPI (Jun. 2026) = 131.3300.

Oryzon Genomics Quarterly Data

Book Value per Share CPI Adj_Book
201609 18.779 99.737 24.728
201612 17.832 101.842 22.995
201703 15.617 100.896 20.328
201706 22.311 101.848 28.769
201709 23.002 101.524 29.755
201712 23.894 102.975 30.473
201803 22.262 102.122 28.629
201806 23.926 104.165 30.166
201809 19.276 103.818 24.384
201812 26.212 104.193 33.039
201903 24.981 103.488 31.702
201906 25.001 104.612 31.386
201909 29.912 103.905 37.807
201912 28.390 105.015 35.504
202003 29.451 103.469 37.381
202006 38.273 104.254 48.213
202009 38.002 103.521 48.211
202012 34.826 104.456 43.786
202103 34.181 104.857 42.810
202106 34.060 107.102 41.765
202109 0.033 107.669 0.040
202112 31.307 111.298 36.942
202203 28.783 115.153 32.827
202206 28.262 118.044 31.443
202209 25.773 117.221 28.875
202212 26.744 117.650 29.854
202303 23.950 118.948 26.443
202306 25.319 120.278 27.645
202309 25.069 121.343 27.132
202312 24.864 121.300 26.920
202403 23.835 122.762 25.499
202406 27.106 124.409 28.614
202409 29.800 123.121 31.787
202412 29.739 124.753 31.307
202503 24.342 125.531 25.467
202506 32.003 127.251 33.029
202509 31.882 126.840 33.011
202512 32.056 128.400 32.787
202603 31.930 129.860 32.291
202606 29.360 131.330 29.360

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of MXN22.47 mean?
Oryzon Genomics (MEX:ORYN) has a Cyclically Adjusted Book per Share of MXN22.47 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Oryzon Genomics and its competitors.
Is Oryzon Genomics' Cyclically Adjusted Book per Share too high?
Oryzon Genomics' current Cyclically Adjusted Book per Share is MXN22.47. Overall, Oryzon Genomics has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Oryzon Genomics' Cyclically Adjusted Book per Share compare to VRTX and REGN?
Oryzon Genomics' Cyclically Adjusted Book per Share of MXN22.47 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Oryzon Genomics and its competitors. Oryzon Genomics's current Cyclically Adjusted Book per Share is MXN22.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oryzon Genomics stock overvalued right now?
Oryzon Genomics (MEX:ORYN) has a current Cyclically Adjusted Book per Share of MXN22.47. The current Cyclically Adjusted Book per Share is MXN22.47. Oryzon Genomics' overall GF Score™ is 29/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Oryzon Genomics (MEX:ORYN), the current Cyclically Adjusted Book per Share is MXN22.47 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oryzon Genomics Business Description

Address Sant Ferran 74, Cornellà de Llobregat, Barcelona, ESP, 08940
Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases.
29GF Score

Get the complete analysis for MEX:ORYN

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN48.59
Price